ExCEEd Orphan announces new members of the team in Adriatic Region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in CEE region, announces new members of the team.
ExCEEd Orphan s.r.o announced today that Irena Stastny, Ivana Halec and Ardian Hasani have joined our team in Adriatic region.

Irena Stastny is joining as Pricing and Market Access Director for Adria Region.
She is successful pharma professional with 15 years of experience in rare diseases and orphan drugs field and 10 years of experience in leading market access and pharma corporate communication.
Irena worked for multiple leading pharma companies like Jonson & Johnson, Lilly, Genzyme , Abbvie and she is a strong communicator with high developed negotiation skills who builds relationship with all levels of management and stakeholders..
Irena is a Croatian native speaker, fluent in English.

Ivana Halec will take a role as Area Manager for Croatia, Slovenia, Bosnia and Herzegovina.
She is experienced pharmaceutical industry professional with both a scientific and business background, with over 12 years of experience working in sales and marketing roles in innovative companies such as Shire, Takeda and Roche.
She is a native Croatian speaker, fluent in English..

Ardian Hasani is joing as Area Manager for North Macedonia, Albania and Kosovo
Ardian is pharmacist by education, a seasoned pharmaceutical professional with more than 15 years of experience in pharmaceutical industry gained in the company Krka. d.d. in multiple sales roles, recognized through the company’s merit system. He possesses in depth knowledge of Macedonian, Albanian and Kosova market, bringing much appreciated know-how and competitive edge to ExCEEd Orphan in these non-EU, but very important markets within the CEE.
Ardian is native in Albanian and Macedonian languages, fluent in English and Bosnian/Croatian/Serbian.

We warmly welcome all three to our team and wish them a lot of success.

Get in touch

With real experts in CEE region.

Send us an e-mail